OCTN acts as a carnitine transporter in the heart, kidney, liver, pancreas, intestine, brain, placenta, trachea, lung, and thyroid
Next Steps If you feel your current treatment has reached its limit or you are interested in the dual-action benefits of tirzepatide, the first step is a clinical evaluation
Location: China, Guangzhou Best for: GHK-Cu serum, copper peptide cream, peptide eye treatment, blue copper peptide mask, ampoule, and multi-peptide skin care
The SURMOUNT-1 trial showed participants losing up to 22.5% of their body weight on the highest dose, compared to approximately 15-17% with semaglutide in the STEP trials
Its purpose is tolerance building, not weight loss
Approximately 90% of deaths from breast cancer are caused by breast cancer metastasis (116)